Vyome Holdings, Inc. (HIND)

Vyome Holdings, Inc. (HIND) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $13.8M; returns 1 day -0.6%, 1 week -4.3%, 1 year -67.6%.

Vyome Holdings, Inc. (NASDAQ: HIND) is a clinical-stage biopharmaceutical company leveraging the US-India innovation corridor to develop therapies for immuno-inflammatory diseases and other unmet medical needs. The company operates as a healthcare platform with interests in biotech, medical devices, and AI in healthcare.

Groups HIND belongs to

• Clinical Stage Biopharma
• Biotechnology
• Healthcare
• Dermatology
• Unmet Medical Needs
• Active M&A Strategy

HIND financial model: income statement, cash flow and balance sheet